Benefits and Risks of Newborn Screening for Cystic Fibrosis - Contacts and Locations

Benefits and Risks of Newborn Screening for Cystic Fibrosis

This study has been completed.
Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00014950

Locations


United States, Wisconsin
	University of Wisconsin
	Madison, Wisconsin, United States, 53706
	Children's Hospital of Wisconsin
	Milwaukee, Wisconsin, United States, 53201
	Children's Hospital of Wisconsin
	Milwaukee, Wisconsin, United States, 53201

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Center for Research Resources (NCRR)

Investigators


Principal Investigator:	Philip M. Farrell, MD, PhD	Dean University of Wisconsin Medical School

Investigator:	Michael J. Rock, M.D.	Dept. Pediatrics, UW Hospital

Investigator:	Mark Splaingard	Children's Hospital and Health System Foundation, Wisconsin

Investigator:	Anita Laxova	Dept. Pediatrics, UW Madison